Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer.


Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common genes relevant to treatment response in a… (More)


  • Presentations referencing similar topics